7,866 results on '"HYPERPHAGIA"'
Search Results
2. OLE Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome
- Published
- 2024
3. Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome
- Published
- 2024
4. fNIRS-based Neurofeedback Intervention for Cognitive Control Improvement in Emotional Overeating (Cemov)
- Author
-
Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement
- Published
- 2024
5. Problematic Decision-Making and Adolescent Weight Loss (REACH)
- Published
- 2024
6. Biobehavioral Reward Responses Associated With Consumption of Nutritionally Diverse Ultra-Processed Foods
- Author
-
Erica Schulte, Assistant Research Professor
- Published
- 2024
7. Understanding the Role of Gut Microbiota in Hyperphagia in Prader-Willi Syndrome (PWSGUT)
- Author
-
Keerthana Kesavarapu, D.O., Assistant Professor
- Published
- 2024
8. Pilot Study of GLY-LOW Supplementation in Postmenopausal Women With Obesity
- Author
-
Buck Institute for Research on Aging, University of Wyoming, and Melinda Sothern, Acting Director of Research Grant and Technical Writer
- Published
- 2024
9. Brain Mechanisms of Overeating in Children (RO1)
- Author
-
Kathleen Loralee Keller, Director
- Published
- 2024
10. Prefrontal-Limbic Circuitry Is Associated With Reward Sensitivity in Nonhuman Primates.
- Author
-
Hur, Kwang-Hyun, Meisler, Steven L., Yassin, Walid, Frederick, Blaise B., and Kohut, Stephen J.
- Subjects
- *
REWARD (Psychology) , *HYPERPHAGIA , *GRAY matter (Nerve tissue) , *CINGULATE cortex , *WHITE matter (Nerve tissue) - Abstract
Abnormal reward sensitivity is a risk factor for psychiatric disorders, including eating disorders such as overeating and binge-eating disorder, but the brain structural mechanisms that underlie it are not completely understood. Here, we sought to investigate the relationship between multimodal whole-brain structural features and reward sensitivity in nonhuman primates. Reward sensitivity was evaluated through behavioral economic analysis in which monkeys (adult rhesus macaques; 7 female, 5 male) responded for sweetened condensed milk (10%, 30%, 56%), Gatorade, or water using an operant procedure in which the response requirement increased incrementally across sessions (i.e., fixed ratio 1, 3, 10). Animals were divided into high (n = 6) or low (n = 6) reward sensitivity groups based on essential value for 30% milk. Multimodal magnetic resonance imaging was used to measure gray matter volume and white matter microstructure. Brain structural features were compared between groups, and their correlations with reward sensitivity for various stimuli was investigated. Animals in the high sensitivity group had greater dorsolateral prefrontal cortex, centromedial amygdaloid complex, and middle cingulate cortex volumes than animals in the low sensitivity group. Furthermore, compared with monkeys in the low sensitivity group, high sensitivity monkeys had lower fractional anisotropy in the left dorsal cingulate bundle connecting the centromedial amygdaloid complex and middle cingulate cortex to the dorsolateral prefrontal cortex, and in the left superior longitudinal fasciculus 1 connecting the middle cingulate cortex to the dorsolateral prefrontal cortex. These results suggest that neuroanatomical variation in prefrontal-limbic circuitry is associated with reward sensitivity. These brain structural features may serve as predictive biomarkers for vulnerability to food-based and other reward-related disorders. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
11. The impact of packaging attributes on portion decisions: Consumer values are important.
- Author
-
Chu, Ruiqi, Tang, Tang, and Hetherington, Marion M.
- Subjects
- *
PROMPTS (Psychology) , *AUTONOMY (Psychology) , *NATURAL foods , *QUALITATIVE research , *CONSUMER attitudes , *INTERVIEWING , *STATISTICAL sampling , *FOOD packaging , *DECISION making , *INTERNET , *HUNGER , *DESCRIPTIVE statistics , *FOOD labeling , *THEMATIC analysis , *HYPERPHAGIA , *SOUND recordings , *RESEARCH methodology , *RESEARCH , *FOOD preferences , *FOOD portions , *DIET - Abstract
Research shows that features of food packaging can help to promote healthy food choices. Laboratory‐based studies demonstrate that smart design of packaging facilitates portion control. However, the extent to which consumers notice packaging features for portion control is not known. Therefore, this study investigated how individuals interact with food packaging, how they utilise the on‐pack serving‐size guidelines and how they make portion decisions. To do this, 25 adult participants were recruited to participate in an online semi‐structured interview. Data were analysed using thematic analysis until saturation was achieved. Participants reported that they rarely attend to on‐pack serving recommendations and indicated some resistance to them. Some structural features (small/single serving, pre‐portioned and resealable packaging) were identified as facilitators of portion control. In contrast, the healthiness evaluation of the product from packaging cues was described as a permissive cue to eat more of the product. Participants in this study value their autonomy and control, preferring convenient behavioural choices over recommended portion servings. They also reported future concerns about the effects of their diet on health, but that current context (hunger, convenience) sometimes presented a barrier to healthy eating. Packaging does more than protect its contents, packaging can affect eating decisions to support portion control, and for some, offers permission to overconsume. This study identified ways that participants use packaging to make portion decisions, revealing the role of habits, current context and future health considerations. The interviews revealed the importance of consumer values on food choice in general and portion control in particular. In conclusion, smart food packaging design could use these findings to nudge healthy portion decisions by incorporating consumer values and by recognising consumer needs for habitual, current and future concerns. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
12. Kleine-Levin syndrome. Clinical boarderlands based on a thorough analysis of 475 case reports.
- Author
-
Billiard, Michel and Jaussent, Isabelle
- Subjects
- *
COMPULSIVE eating , *LIBIDO , *COGNITION disorders , *SLEEP disorders , *HYPERPHAGIA - Abstract
Kleine-Levin syndrome (KLS) is a rare sleep disorder characterized by recurrent episodes of severe hypersomnolence in association with various degrees of cognitive impairment, perceptive abnormalities, apathy, behavioral disturbances. Some of these symptoms, hypersomnolence, compulsive eating and increased sexual drive may be replaced by their opposites or alternate with them. Remarkably enough, these « atypical symptoms » have never been enlighted nor compared in frequency with corresponding typical symptoms. Besides, KLS is more frequent in males than in females but no review has ever compared the frequency of precipitating factors and symptoms in males and females. To uncover these as yet uninvestigated aspects of KLS, a predesigned template was used to extract precipitating factors and symptoms, in 475 case reports of KLS, comprising 364 males and 111 females. Precipitating factors were more frequently recorded in males (67.31 %) than in females (49.55 %). Recurrent episodes of hypersomnolencee were present in 94.32 % of cases, recurrent insomnia in 1.05 % and alternation of hypersomnolence and insomnia in 4.63 %. Cognitive impairment was present in 67.37 % of cases and absent in 6.95 %. Derealization/altered perception was present in 38.32 % of cases and absent in 1.68 %. Severe apathy was present in 44.63 % of cases. Compulsive eating was present in 59.58 % of cases, absent in 13.26 %, replaced by anorexia in 9.05 %, alternation of compulsive eating and anorexia in 5.68 % and alternation of compulsive eating and no compulsive eating in 8.42 %. Increased sexual drive was present in 33.68 % of cases, absent in 22.74 %, replaced by decreased sexual drive in 1.47 %, alternation of increased sexual drive and no increased sexual drive in 2.95 %. Odd behaviors were present in 45.05 % of cases. Psychiatric features were present in 71.58 % of cases, absent in 2.95 %. Finally, the percentages of precipitating factors and of sleep disorder, apathy, sexual disorder, irritability/agressivity, were higher in males than in females. The frequency of the opposites of hypersomnolence, compulsive eating and increased sexual drive appears to be quite significant. In addition, a systematic comparison of precipitating factors and symptoms in males and females has shown limited differences between sexes. • Naming of Kleine-Levin symptoms must be standardized. • A review of KLS symptoms must include presence, absence and absence of data. • Hypersomnolence, hyperphagia, hypersexuality may be replaced by their opposite or alternate with it. • Comparison of precipitating factors and symptoms between sexes has shown minor differences. • Diagnostic criteria of Kleine-Levin syndrome should be updated. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
13. Momentary stress‐induced food craving: An ecological momentary assessment study comparing perceived interpersonal and non‐interpersonal stressors.
- Author
-
Dicker‐Oren, Sheila Daniela, Gelkopf, Marc, and Greene, Talya
- Subjects
- *
RESEARCH funding , *DESIRE , *HYPERPHAGIA , *PSYCHOLOGICAL stress , *QUALITY of life , *FOOD preferences , *INTERPERSONAL relations , *COMPARATIVE studies - Abstract
Daily‐life stressors and food cravings are dynamic and vary within and across persons. Some evidence suggests interpersonal stressors increase appetite. However, little is known about the association of food craving with different types of stressors at the momentary level in the general population. We aimed to explore the momentary relationships between daily‐life stressful events and food craving in a non‐clinical community sample, and to compare the associations with food craving when the most stressful event was perceived as interpersonal versus non‐interpersonal. We used ecological momentary assessment (EMA) to collect reports on the most stressful event, perceived stressor type, stressor appraisal, and food craving from 123 adults three times a day scheduled at fixed intervals over 10 days. Mixed effects random intercepts and slopes models examined the within‐ and between‐person associations. Experiencing a stressor was significantly positively associated with within‐person food craving at the same measurement. No differences in momentary food craving were found when the most stressful event was perceived as interpersonal or non‐interpersonal (within‐person level). However, frequently reporting the most stressful event as interpersonal (vs. non‐interpersonal) was positively associated with food craving across the study (between‐person level), particularly when the stressor was appraised as more unpleasant. Daily‐life stressors were associated with momentary food craving. Individuals who generally perceived interpersonal stressors as their most stressful event tended to experience food cravings. Future research could further investigate the role of interpersonal stressors as a factor for overeating in daily life and the potential benefits of stress management in interventions. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
14. GNB1 and obesity: Evidence for a correlation between haploinsufficiency and syndromic obesity.
- Author
-
Kleinendorst, Lotte, Abawi, Ozair, Vos, Niels, van der Valk, Eline S., Maas, Saskia M., Morgan, Angela T., Hildebrand, Michael S., Da Silva, Jorge D., Florijn, Ralph J., Lauffer, Peter, Visser, Jenny A., van Rossum, Elisabeth F. C., van den Akker, Erica L. T., and van Haelst, Mieke M.
- Subjects
- *
OBESITY , *DEVELOPMENTAL delay , *HYPERPHAGIA , *PHENOTYPES - Abstract
Summary: Most patients with GNB1 encephalopathy have developmental delay and/or intellectual disability, brain anomalies and seizures. Recently, two cases with GNB1 encephalopathy caused by haploinsufficiency have been reported that also show a Prader–Willi‐like phenotype of childhood hypotonia and severe obesity. Here we present three new cases from our expert centre for genetic obesity in which GNB1 truncating and splice variants, probably leading to haploinsufficiency, were identified. They all have obesity, hyperphagia and intellectual deficit. The clinical cases and their weight courses are presented, together with a review of all 68 published cases with GNB1 encephalopathy. Information on weight was not mentioned in most of these articles, so we contacted authors for additional clinical information on weight status and hyperphagia. Of the 42 patients whose weight status we could determine, obesity was present in 8 patients (19%). Obesity is significantly over‐represented in the group with truncating and splicing variants. In this group, we see an obesity prevalence of 75%. Since GNB1 has been linked to several key genes in the hypothalamic leptin‐melanocortin pathway, which regulates satiety and energy expenditure, our data support the potential association between GNB1 haploinsufficiency and genetic obesity. We also suggest GNB1 is a candidate gene for the known obesity phenotype of the 1p36 microdeletion syndrome given this chromosomal region includes the GNB1 gene. Knowledge of an additional obesity phenotype is important for prognosis, early interventions against obesity and awareness when prescribing weight‐inducing medication. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
15. Hibernating or not hibernating? Brown bears' response to a mismatch between environmental natural cues and captive management, and its welfare implications.
- Author
-
Dori, Paolo, Anastasio, Isabella, Macchi, Elisabetta, Manenti, Isabella, Hones, Maik, and Carosi, Monica
- Subjects
- *
BROWN bear , *BEAR behavior , *HIBERNATION , *HYPERPHAGIA , *WELL-being - Abstract
In wild brown bears, likely factors triggering hibernation response to harsh environmental conditions are temperature, photoperiod, and food resources availability. In fact, constantly fed captive brown bears are described as skipping hibernation being active all year-round. Is the hibernation response so flexible and subordinate to contingencies, or else is an adaptation that, if dismissed, may negatively impact on bear well-being? This study investigates the potential hibernation response in captive brown bears under unvaried management conditions using an integrative approach simultaneously analyzing multiple animal-based variables together with environmental covariates. Data from a mid-latitude zoo revealed distinct behavioral, fecal glucocorticoids, and body condition score seasonal fluctuations, resembling natural hibernation cycles, despite constant food access. Environmental variables like photoperiod and visitor numbers significantly influenced activity levels. Bears exhibited behaviors indicative of hyperphagia and fall transition, such as appetitive feeding and denning behaviors. Hormonal analyses revealed high fecal cortisol metabolites levels during hyperphagia, suggesting physiological responses to seasonal changes. Findings underscore the importance of environmental cues and food availability in shaping zoo bear behavior and physiology. Considering that the hibernating vs. non-hibernating description might represent an oversimplification, management strategies should deal with captive bear potential need to freely express their adaptive predispositions by accommodating their natural behaviors, such as providing denning spots and adjusting diet composition as soon as typical hyperphagic and predenning behaviors emerge, ultimately enhancing their well-being. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
16. Morbid hunger and hyperphagia post-traumatic brain injury in a young male: good prognosis with escitalopram and multidisciplinary rehabilitation.
- Author
-
Zainudin, Muhamad Faizal, Yee, Cha Mei, and Nyein Yin, Khin
- Subjects
- *
BRAIN injuries , *HYPERPHAGIA , *PROGNOSIS , *HUNGER , *NEUROLOGICAL disorders , *FRONTAL lobe diseases - Abstract
ObjectiveMethodResultsConclusionMorbid hunger and hyperphagia (MHH) is a rare neurological disorder that can manifest following damage to the right frontal and temporal lobes. It can lead to detrimental short and long-term complications such as electrolyte imbalances, obesity, and cardiovascular diseases. This report details the case of a young male patient who developed MHH five months post-traumatic brain injury.Single-case report. The patient exhibited colossal appetite, overeating, food-demanding behavior, and rapid weight gain. The prescription of quetiapine to manage his visual and auditory hallucinations was suspected of exacerbating the hyperphagia. A comprehensive, multidisciplinary rehabilitation approach was implemented, encompassing a meticulous dietary regime, environmental modifications, behavioral management, physical activities, therapeutic exercises, and pharmacological interventions, which included switching the anti-psychotics and introducing low-dose escitalopram.Over the course of 6 months, the MHH gradually subsided, and the patient achieved the target bodyweight. The Glasgow Outcome Scale-Extended improved from 3 to 5.This is the first report on the use of escitalopram to manage secondary eating disorders. Our findings underscore the necessity to formally catalog and recognize disorders like MHH in diagnostic classifications to facilitate the systematic study of their pathophysiology, natural history, prognosis, and management strategies. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
17. Mothering a Child With Complexity and Rarity: A Narrative Inquiry Exploring Prader-Willi Syndrome.
- Author
-
Currie, Genevieve, Estefan, Andrew, and Caine, Vera
- Subjects
- *
PRADER-Willi syndrome , *RESEARCH funding , *STATISTICAL sampling , *PARENTING , *HUNGER , *JUDGMENT sampling , *EXPERIENCE , *HYPERPHAGIA , *PSYCHOLOGY of mothers , *RESEARCH methodology , *QUALITY of life - Abstract
Daily experiences of mothers caring for children with Prader-Willi syndrome (PWS) are largely unknown and unvoiced. Knowledge of PWS has generally focused on pathology of the disorder. This emphasis overlooks the challenging moments of everyday life caring for children with PWS. Storied accounts of mothers caring for children with PWS offer expanded narratives to medicalized descriptions of experience. An understanding of everyday challenges in managing physical and mental health issues of PWS including hyperphagia and anxiety may create shifts in social and clinical perspectives. This understanding could improve practices in health and social care for families with PWS. This narrative inquiry studied everyday experience using storied accounts. Participants were mothers caring for children aged 3–17 years with genetically confirmed PWS who were experiencing hyperphagia. Four participants were recruited, and each interviewed 8–12 times over 12 months. Field texts and narrative accounts were co-composed through a collaborative process of analysis. Engaging with participants' day-to-day experiences offered insights into their work of nurturing, caring, and contributing to the care of a child with PWS. Narrative threads focused on complexity and rarity and include the desire to be normal, how ordinary becomes extraordinary, isolation, behaviors and normative standards, and alternative stories of mothering. Recommendations for practice and policy include (a) challenges of mothering a child with complexity, (b) moving beyond functionality and impairment to participation and quality of life, (c) re-storying narratives and supports for families, and (d) engaging with mothers to determine care priorities. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
18. Stability of child appetitive traits and association with diet quality at 5 years and 9–11 years old: Findings from the ROLO longitudinal birth cohort study.
- Author
-
Delahunt, Anna, Killeen, Sarah Louise, O'Brien, Eileen C., Geraghty, Aisling A., O'Reilly, Sharleen L., McDonnell, Ciara M., Cushion, Rosemary, Mehegan, John, and McAuliffe, Fionnuala M.
- Subjects
FOOD quality ,SECONDARY analysis ,SATISFACTION ,RESEARCH funding ,MOTHERS ,QUESTIONNAIRES ,MULTIPLE regression analysis ,FOOD fussiness ,APPETITE ,DESCRIPTIVE statistics ,LONGITUDINAL method ,HYPERPHAGIA ,FOOD habits ,COMPARATIVE studies ,FOOD preferences ,DIET ,CHILD behavior ,INTUITIVE eating ,CHILDREN - Abstract
Background: We explored change in child appetitive traits from 5 to 9–11 years old and examined associations between appetitive traits at both timepoints and child diet quality. Methods: This is secondary analyses of the ROLO longitudinal birth cohort study, including mother-child dyads from the 5 and 9–11-year old follow-up. The Children's Eating Behaviour Questionnaire measured child appetitive traits, with 167 children having matched data for both timepoints. The Healthy Eating Index (HEI) measured diet quality. Linear mixed models and multiple linear regression were completed. Results: Mean (SD) score for 'Emotional Overeating' (1.63 (0.51) vs. 1.99 (0.57), p = <0.001) and 'Enjoyment of Food' (3.79 (0.72) vs. 3.98 (0.66), p = <0.001) increased from 5 to 9–11 years. Mean score for 'Desire to Drink' (2.63 (0.94) vs. 2.45 (0.85), p = 0.01), 'Satiety Responsiveness (3.07 (0.66) vs. 2.71 (0.66), p = <0.001), 'Slowness Eating' (3.02 (0.77) vs. 2.64 (0.78), p = <0.001), and 'Food Fussiness' (3.00 (1.04) vs. 2.81 (0.96), p = 0.001) decreased. At 5-years-old, 'Food Responsiveness' and 'Enjoyment of Food' were positively associated with HEI and 'Desire to Drink', 'Satiety Responsiveness' and 'Food Fussiness' were negatively associated with HEI. At 9–11-years, 'Enjoyment of Food' was positively and 'Desire to Drink' and 'Food 'Fussiness' were negatively associated with HEI. Conclusions: Food approach appetitive traits increased over time, whereas food avoidant appetitive traits tended to decrease. At both time points 'Food Fussiness' and 'Desire to Drink" were inversely associated with HEI. Further research on how appetitive traits track over childhood and how this relates to dietary quality and weight is warranted. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
19. Therapeutic Strategies Against Metabolic Imbalance in a Male Mouse Model With 5-HT2CR Loss-of-Function.
- Author
-
Liu, Hailan, Liu, Zhaoxun, Wong, HueyXian Kelly, Xu, Nathan, Liu, Qingzhuo, Li, Yongxiang, Liu, Yao, Wong, HueyZhong, Burt, Megan E, Jossy, Sanika V, Han, Junying, and He, Yang
- Subjects
MALE models ,LABORATORY mice ,MELANOCORTIN receptors ,ANIMAL disease models ,SEROTONIN receptors ,HYPERGLYCEMIA ,RUNNING injuries - Abstract
The serotonin 2C receptor (5-HT
2C R)-melanocortin pathway plays well-established roles in the regulation of feeding behavior and body weight homeostasis. Dysfunctions in this system, such as loss-of-function mutations in the Htr2c gene, can lead to hyperphagia and obesity. In this study, we aimed to investigate the potential therapeutic strategies for ameliorating hyperphagia, hyperglycemia, and obesity associated with a loss-of-function mutation in the Htr2c gene (Htr2cF327L/Y ). We demonstrated that reexpressing functional 5-HT2C R solely in hypothalamic pro-opiomelanocortin (POMC) neurons is sufficient to reduce food intake and body weight in Htr2cF327L/Y mice subjected to a high-fat diet (HFD). In addition, 5-HT2C R expression restores the responsiveness of POMC neurons to lorcaserin, a selective agonist for 5-HT2C R. Similarly, administration of melanotan II, an agonist of the melanocortin receptor 4 (MC4R), effectively suppresses feeding and weight gain in Htr2cF327L/Y mice. Strikingly, promoting wheel-running activity in Htr2cF327L/Y mice results in a decrease in HFD consumption and improved glucose homeostasis. Together, our findings underscore the crucial role of the melanocortin system in alleviating hyperphagia and obesity related to dysfunctions of the 5-HT2C R, and further suggest that MC4R agonists and lifestyle interventions might hold promise in counteracting hyperphagia, hyperglycemia, and obesity in individuals carrying rare variants of the Htr2c gene. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
20. GHSR in a Subset of GABA Neurons Controls Food Deprivation-Induced Hyperphagia in Male Mice.
- Author
-
Cornejo, María Paula, Fernandez, Gimena, Cabral, Agustina, Barrile, Franco, Heredia, Florencia, Romero, Guadalupe García, Sampieri, Juan Pablo Zubimendi, Quelas, Juan Ignacio, Cantel, Sonia, Fehrentz, Jean-Alain, Alonso, Antonia, Pla, Ramon, Ferran, José Luis, Andreoli, María Florencia, Francesco, Pablo Nicolas De, and Perelló, Mario
- Subjects
GHRELIN receptors ,GLUTAMATE decarboxylase ,FOOD supply ,GABA ,HYPERPHAGIA - Abstract
The growth hormone secretagogue receptor (GHSR), primarily known as the receptor for the hunger hormone ghrelin, potently controls food intake, yet the specific Ghsr-expressing cells mediating the orexigenic effects of this receptor remain incompletely characterized. Since Ghsr is expressed in gamma-aminobutyric acid (GABA)–producing neurons, we sought to investigate whether the selective expression of Ghsr in a subset of GABA neurons is sufficient to mediate GHSR's effects on feeding. First, we crossed mice that express a tamoxifen-dependent Cre recombinase in the subset of GABA neurons that express glutamic acid decarboxylase 2 (Gad2) enzyme (Gad2-CreER mice) with reporter mice, and found that ghrelin mainly targets a subset of Gad2 -expressing neurons located in the hypothalamic arcuate nucleus (ARH) and that is predominantly segregated from Agouti-related protein (AgRP)–expressing neurons. Analysis of various single-cell RNA-sequencing datasets further corroborated that the primary subset of cells coexpressing Gad2 and Ghsr in the mouse brain are non-AgRP ARH neurons. Next, we crossed Gad2-CreER mice with reactivable GHSR-deficient mice to generate mice expressing Ghsr only in Gad2 -expressing neurons (Gad2-GHSR mice). We found that ghrelin treatment induced the expression of the marker of transcriptional activation c-Fos in the ARH of Gad2-GHSR mice, yet failed to induce food intake. In contrast, food deprivation–induced refeeding was higher in Gad2-GHSR mice than in GHSR-deficient mice and similar to wild-type mice, suggesting that ghrelin-independent roles of GHSR in a subset of GABA neurons is sufficient for eliciting full compensatory hyperphagia in mice. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
21. Cannabidiol versus placebo as adjunctive treatment in early psychosis: study protocol for randomized controlled trial.
- Author
-
Dixon, T and Cadenhead, K
- Subjects
Attenuated psychosis syndrome ,Cannabidiol ,Hyperphagia ,Inflammation ,Metabolism ,Psychosis ,Schizophrenia ,Stress ,Young Adult ,Humans ,Cannabidiol ,Psychotic Disorders ,Anxiety ,Antipsychotic Agents ,Affect ,Randomized Controlled Trials as Topic - Abstract
BACKGROUND: Psychotic disorders are a leading cause of disability in young adults. Antipsychotics have been the primary intervention for psychosis for over 60 years, and yet, we have made little progress in treating negative symptoms, neurocognition, and functional disability. There is growing evidence that cannabidiol (CBD) is effective in treating positive psychotic symptoms, possibly also negative and neurocognitive symptoms, and moreover is well tolerated compared to other psychotropic medications. Anecdotally, patients participating in the Cognitive Assessment and Risk Evaluation (CARE) Early Psychosis Treatment Program at the University of California, San Diego, are self-administering CBD and report subjective improvement in stress, anxiety, and ability to cope with symptoms. The overarching aim of the trial is to explore the effectiveness of CBD augmentation on symptoms and neurocognition in early psychosis while also exploring the mechanism of action of CBD and predictors of response to treatment. The mechanism by which cannabidiol has a therapeutic effect on psychosis is poorly understood. Recent evidence has suggested that CBD may reduce stress and pro-inflammatory biomarker levels. Endocannabinoids also have powerful roles in eating behavior, reward, and mood, indicating these neurotransmitters may play a role in reducing hyperphagia and metabolic abnormalities that are present early in the course of psychotic illness and exacerbated by antipsychotic medication. The neurophysiological effects of CBD have been studied in animal models of psychosis that show improvements in information processing in response to CBD, but there are no studies in individuals with early psychosis. METHOD: A total of 120 individuals in the early stages of psychosis will be randomized to 1000 mg of CBD versus placebo as an adjunct to existing treatment in a 8-week, double-blind superiority randomized control trial. The primary outcome measures are symptoms and neurocognition. DISCUSSION: We hypothesized that CBD will improve symptoms and neurocognition as well as secondary outcome measures of neurohormones, inflammation, eating behaviors, and information processing. Importantly, predictors, moderators, and mediators of the CBD effects will be examined. A better understanding of which individuals are likely to respond to CBD can inform treatment planning and personalize treatment. TRIAL REGISTRATION: ClinicalTrials.gov NCT04411225. Registered on June 2, 2020.
- Published
- 2023
22. Targeting Clic1 for the treatment of obesity: A novel therapeutic strategy to reduce food intake and body weight
- Author
-
Zapata, Rizaldy C, Zhang, Dinghong, Yoon, Dongmin, Nasamran, Chanond A, Chilin-Fuentes, Daisy R, Libster, Avraham, Chaudry, Besma S, Lopez-Valencia, Mariela, Ponnalagu, Devasena, Singh, Harpreet, Petrascheck, Michael, and Osborn, Olivia
- Subjects
Biochemistry and Cell Biology ,Biological Sciences ,Obesity ,Genetics ,Nutrition ,5.1 Pharmaceuticals ,2.1 Biological and endogenous factors ,Cardiovascular ,Metabolic and endocrine ,Stroke ,Cancer ,Oral and gastrointestinal ,Animals ,Mice ,Mice ,Obese ,Body Weight ,Weight Gain ,Mice ,Knockout ,Eating ,Chloride Channels ,Antigens ,Neoplasm ,Proteins ,Food intake ,Clic1 ,Hyperphagia ,Body weight regulation ,Physiology ,Biochemistry and cell biology - Abstract
ObjectiveDespite great advances in obesity therapeutics in recent years, there is still a need to identify additional therapeutic targets for the treatment of this disease. We previously discovered a signature of genes, including Chloride intracellular channel 1 (Clic1), whose expression was associated with drug-induced weight gain, and in these studies, we assess the effect of Clic1 inhibition on food intake and body weight in mice.MethodsWe studied the impact of Clic1 inhibition in mouse models of binge-eating, diet-induced obese mice and genetic models of obesity (Magel2 KO mice).ResultsClic1 knockout (KO) mice ate significantly less and had a lower body weight than WT littermates when either fed chow or high fat diet. Furthermore, pharmacological inhibition of Clic1 in diet-induced obese mice resulted in suppression of food intake and promoted highly efficacious weight loss. Clic1 inhibition also reduced food intake in binge-eating models and hyperphagic Magel2 KO mice. We observed that chronic obesity resulted in a significant change in subcellular localization of Clic1 with an increased ratio of Clic1 in the membrane in the obese state. These observations provide a novel therapeutic strategy to block Clic1 translocation as a potential mechanism to reduce food intake and lower body weight.ConclusionsThese studies attribute a novel role of Clic1 as a driver of food intake and overconsumption. In summary, we have identified hypothalamic expression of Clic1 plays a key role in food intake, providing a novel therapeutic target to treat overconsumption that is the root cause of modern obesity.
- Published
- 2023
23. Early Intervention in Cognitive Aging
- Author
-
Robert Krikorian, Professor
- Published
- 2023
24. Impact of Bright Light Therapy on Prader-Willi Syndrome (PWS-LT)
- Author
-
Foundation for Prader-Willi Research
- Published
- 2023
25. tDCS for Impulsivity and Compulsivity in Obesity
- Author
-
Center for Veterans Research and Education and Shalamar Sibley, MD, MPH, Associate Professor of Medicine, University of Minnesota; Minneapolis VAMC Staff Physician
- Published
- 2023
26. Kleine Levin syndrome – presentation of five cases
- Author
-
Varaha Venkat Gantait, Imon Paul, Adnan Jamil, and Anamika Das
- Subjects
hyperphagia ,hypersomnia ,kleine levin syndrome ,Psychiatry ,RC435-571 - Abstract
Kleine Levin syndrome (KLS) is a rare entity. It presents with subacute onset episodic hypersomnia, cognitive decline, altered perception, and occasional hyperphagia and hypersexuality with full recovery during the interepisodic period. Five cases presented with episodic hypersomnia and met the diagnostic criteria of KLS. The majority of the cases were females (3/5) in whom KLS is even rarer. The initial presentation was in the age range of 10–25 years. Cognitive dysfunction (5/5), derealization (4/5), viral prodrome (3/5), hyperphagia (3/5), and hypersexuality (2/5) were other clinical presentations. A differential diagnosis of atypical depression is the major challenge, and thorough history taking would help in differentiation. Treatment with stimulants (modafinil) and mood stabilizers (lithium) proved effective. A high degree of suspicion should be kept for cases of episodic hypersomnolence for early diagnosis and management of KLS.
- Published
- 2024
- Full Text
- View/download PDF
27. Behavioral changes in patients with Prader-Willi syndrome receiving diazoxide choline extended-release tablets compared to the PATH for PWS natural history study
- Author
-
Theresa V. Strong, Jennifer L. Miller, Shawn E. McCandless, Evelien Gevers, Jack A. Yanovski, Lisa Matesevac, Jessica Bohonowych, Shaila Ballal, Kristen Yen, Patricia Hirano, Neil M. Cowen, and Anish Bhatnagar
- Subjects
Prader-Willi syndrome ,Hyperphagia ,Natural history ,DCCR ,Neurosciences. Biological psychiatry. Neuropsychiatry ,RC321-571 - Abstract
Abstract Background Prader-Willi syndrome (PWS) is a rare neurobehavioral-metabolic disease caused by the lack of paternally expressed genes in the chromosome 15q11-q13 region, characterized by hypotonia, neurocognitive problems, behavioral difficulties, endocrinopathies, and hyperphagia resulting in severe obesity if energy intake is not controlled. Diazoxide choline extended-release (DCCR) tablets have previously been evaluated for their effects on hyperphagia and other behavioral complications of people with PWS in a Phase 3 placebo-controlled study of participants with PWS, age 4 and older with hyperphagia (C601) and in an open label extension study, C602. Methods To better understand the longer-term impact of DCCR, a cohort from PATH for PWS, a natural history study that enrolled participants with PWS age 5 and older, who met the C601 age, weight and baseline hyperphagia inclusion criteria and had 2 hyperphagia assessments ≥ 6 months apart, were compared to the C601/C602 cohort. Hyperphagia was measured using the Hyperphagia Questionnaire for Clinical Trials (HQ-CT, range 0–36). The primary analysis used observed values with no explicit imputation of missing data. A sensitivity analysis was conducted in which all missing HQ-CT assessments in the C601/C602 cohort were assigned the highest possible value (36), representing the worst-case scenario. Other behavioral changes were assessed using the Prader-Willi Syndrome Profile questionnaire (PWSP). Results Relative to the PATH for PWS natural history study cohort, the DCCR-treated C601/C602 cohort showed significant improvements in HQ-CT score at 26 weeks (LSmean [SE] -8.3 [0.75] vs. -2.5 [0.43], p
- Published
- 2024
- Full Text
- View/download PDF
28. Kleine Levin syndrome -- presentation of five cases.
- Author
-
Gantait, Varaha Venkat, Paul, Imon, Jamil, Adnan, and Das, Anamika
- Subjects
- *
THERAPEUTIC use of lithium , *DIFFERENTIAL diagnosis , *MODAFINIL , *EARLY medical intervention , *CENTRAL nervous system stimulants , *KLEINE-Levine syndrome , *HYPERSOMNIA , *PERCEPTUAL disorders , *HYPERPHAGIA , *HYPERSEXUALITY , *DEPERSONALIZATION , *COGNITION disorders , *EARLY diagnosis , *MENTAL depression , *SYMPTOMS - Abstract
Kleine Levin syndrome (KLS) is a rare entity. It presents with subacute onset episodic hypersomnia, cognitive decline, altered perception, and occasional hyperphagia and hypersexuality with full recovery during the interepisodic period. Five cases presented with episodic hypersomnia and met the diagnostic criteria of KLS. The majority of the cases were females (3/5) in whom KLS is even rarer. The initial presentation was in the age range of 10--25 years. Cognitive dysfunction (5/5), derealization (4/5), viral prodrome (3/5), hyperphagia (3/5), and hypersexuality (2/5) were other clinical presentations. A differential diagnosis of atypical depression is the major challenge, and thorough history taking would help in differentiation. Treatment with stimulants (modafinil) and mood stabilizers (lithium) proved effective. A high degree of suspicion should be kept for cases of episodic hypersomnolence for early diagnosis and management of KLS. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
29. Detraining after short‐term exercise induces hyperphagia and obesity with fatty liver and brown adipose tissue whitening in young male OLETF rats.
- Author
-
Oshima, Takaya, Takaishi, Kaho, Nishihira, Misuzu, Nguyen, Son Tien, Urakawa, Susumu, Ohno, Haruya, and Fujita, Naoto
- Subjects
- *
BROWN adipose tissue , *WHITE adipose tissue , *HYPERPHAGIA , *OBESITY , *RATS , *FATTY liver , *ADIPOSE tissue diseases - Abstract
This study examined the effects of exercise and detraining at a young age on fat accumulation in various organs. Four‐week‐old male Otsuka Long‐Evans Tokushima Fatty (OLETF) rats were assigned to either the non‐exercise sedentary (OLETF Sed) or exercise groups. The exercise group was subdivided into two groups: exercise between 4 and 12 weeks of age (OLETF Ex) and exercise between 4 and 6 weeks of age followed by non‐exercise between 6 and 12 weeks of age (OLETF DT). Body weight was significantly lower in the OLETF Ex group than in the OLETF Sed group at 12 weeks of age. Fat accumulation in the epididymal white adipose tissue, liver, and brown adipose tissue was suppressed in the OLETF Ex group. During the exercise period, body weight and food intake in the OLETF DT group were significantly lower than those in the OLETF Sed group. However, food intake was significantly higher in the OLETF DT group than in the OLETF Sed group after exercise cessation, resulting in extreme obesity with fatty liver and brown adipose tissue whitening. Detraining after early‐onset exercise promotes hyperphagia, causing extreme obesity. Overeating should be avoided during detraining periods in cases of exercise cessation at a young age. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
30. IMPROVE 2022 International Meeting on Pathway‐Related Obesity: Vision of Excellence.
- Author
-
Kühnen, Peter, Argente, Jesús, Clément, Karine, Dollfus, Hélène, Dubern, Béatrice, Farooqi, Sadaf, de Groot, Corjan, Grüters, Annette, Holm, Jens‐Christian, Hopkins, Mark, Kleinendorst, Lotte, Körner, Antje, Meeker, David, Rydén, Mikael, von Schnurbein, Julia, Tschöp, Matthias, Yeo, Giles S. H., Zorn, Stefanie, and Wabitsch, Martin
- Subjects
- *
ACADEMIC medical centers , *GENETIC testing , *RESEARCH personnel - Abstract
Summary: Nearly 90 clinicians and researchers from around the world attended the first IMPROVE 2022 International Meeting on Pathway‐Related Obesity. Delegates attended in person or online from across Europe, Argentina and Israel to hear the latest scientific and clinical developments in hyperphagia and severe, early‐onset obesity, and set out a vision of excellence for the future for improving the diagnosis, treatment, and care of patients with melanocortin‐4 receptor (MC4R) pathway‐related obesity. The meeting co‐chair Peter Kühnen, Charité Universitätsmedizin Berlin, Germany, indicated that change was needed with the rapidly increasing prevalence of obesity and the associated complications to improve the understanding of the underlying mechanisms and acknowledge that monogenic forms of obesity can play an important role, providing insights that can be applied to a wider group of patients with obesity. World‐leading experts presented the latest research and led discussions on the underlying science of obesity, diagnosis (including clinical and genetic approaches such as the role of defective MC4R signalling), and emerging clinical data and research with targeted pharmacological approaches. The aim of the meeting was to agree on the questions that needed to be addressed in future research and to ensure that optimised diagnostic work‐up was used with new genetic testing tools becoming available. This should aid the planning of new evidence‐based treatment strategies for the future, as explained by co‐chair Martin Wabitsch, Ulm University Medical Center, Germany. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
31. Hyperprogesteronism associated with adrenocortical tumours in two dogs.
- Author
-
Farges, Anais, Crawford, Dave, da Silva, Carlos Adrega, and Ramsey, Ian
- Subjects
SYMPTOMS ,COMPUTED tomography ,TUMORS ,WEIGHT gain ,DOGS ,HYPERPHAGIA - Abstract
A 9‐year‐old, entire, female, soft‐coated Wheaten terrier and a 7‐year‐old, male, neutered greyhound were presented for clinical signs suggestive of hyperadrenocorticism (polyuria, polydipsia, and in the first case, polyphagia and weight gain). Adrenocorticotrophic hormone stimulation test and low‐dose dexamethasone suppression test ruled out excessive production of cortisol. Imaging (abdominal ultrasound and computed tomography) revealed an adrenal mass in both cases. Further hormonal testing revealed hyperprogesteronism. In the first case, surgical treatment was not considered due to vascular invasion of the mass, the patient was treated successfully with trilostane and was still stable 18 months later. In the second case, adrenalectomy was performed, and the clinical signs resolved, the dog was stable 10 months later. We report two clinical cases of progesterone‐secreting adrenocortical tumours and their management. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
32. Prader–Willi syndrome in a large sample from Spain: general features, obesity and regular use of psychotropic medication.
- Author
-
González‐Domenech, P. J., Gurpegui, M., González‐Domenech, C. M., Gómez‐González, S., Rustarazo, A., Ruiz‐Nieto, V., Carretero, M. D., and Gutiérrez‐Rojas, L.
- Subjects
- *
PRADER-Willi syndrome , *CLINICAL medicine , *CROSS-sectional method , *LIFESTYLES , *HABIT , *BEHAVIOR disorders , *BODY mass index , *KEY performance indicators (Management) , *LOGISTIC regression analysis , *SYMPTOMS , *DESCRIPTIVE statistics , *LONGITUDINAL method , *HYPERPHAGIA , *STATISTICS , *COMPULSIVE skin picking , *COGNITION disorders , *ANTHROPOMETRY , *HYPERKINESIA , *OBESITY , *PSYCHIATRIC drugs , *DEMOGRAPHY , *PHYSICAL activity , *DISEASE complications - Abstract
Background: Prader–Willi syndrome (PWS), a genetically determined disorder, the most frequent cause of early onset obesity, is associated with physical and cognitive dysfunctions and behavioural disturbances; these disturbances are frequently treated with psychotropic medication. The aim of this cross‐sectional study was to describe the characteristics of the first large national sample of persons with PWS in Spain and analyse the relationships of those characteristics with key demographic and clinical factors, particularly with obesity and the regular use of psychotropic medication. Methods: Participants were recruited among all members of the Spanish Prader–Willi Association who agreed to take part in the study and fulfilled its inclusion criteria. Family and patient demographic features, family size and birth order, intelligence quotient (IQ), anthropometric measures, lifestyle habits, behavioural disturbances (with the Aberrant Behavior Checklist) and clinical data, as well as use of psychotropic drugs and their side effects (with the UKU scale), were collected in genetically confirmed cases of PWS. Bivariate and logistic regression analyses were used for determining the associations of demographic and clinical factors with both obesity and the regular use of psychotropic medication. Results: The cohort included 177 participants (aged 6–48 years), that is, 90 (50.8%) males and 87 (49.2%) females. Behavioural disturbances were present in a range of 75% to 93% of participants; psychotropic medication was prescribed to 81 (45.8%) of them. Number of siblings showed a direct correlation with IQ, especially among males, and inappropriate speech was more intense in only‐child females. Obesity was, in parallel, strongly associated with ascending age and with not being currently under growth hormone (GH) treatment. Participants taking any psychotropic medication were characterised by more frequent age ≥30 years, high level of hyperactivity and a psychiatric diagnosis. Conclusions: Characterisation of persons with PWS in Spain confirms their physical and behavioural phenotype and supports the long‐term application of GH therapy and the rational use of psychotropic medication. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
33. Long-term changes in eating-related problems and quality of life in children with overweight and obesity attending a 10-week lifestyle camp.
- Author
-
Jakobsen, Dorthe Dalstrup, Järvholm, Kajsa, Brader, Lea, and Bruun, Jens Meldgaard
- Subjects
WEIGHT loss ,SELF-evaluation ,BULIMIA ,BEHAVIOR modification ,QUESTIONNAIRES ,PROBABILITY theory ,LONELINESS ,DESCRIPTIVE statistics ,RELATIVE medical risk ,CHI-squared test ,HYPERPHAGIA ,HEALTH behavior ,QUALITY of life ,CHILDHOOD obesity ,HEALTH promotion ,CONFIDENCE intervals ,PATIENT aftercare ,SOCIAL problems ,CHILDREN - Abstract
Eating-related problems (e.g., binge eating (BE)) and impaired quality of life (QoL) is more prevalent in children with overweight and obesity. This study aimed to investigate changes in self-reported overeating (OE), BE, and QoL in children with overweight or obesity attending multicomponent 10-week lifestyle camps with a 52-weeks follow-up. Additionally, the study sought to investigate whether self-reported OE/BE before camp was associated with changes in QoL. Children aged 7 to 14-years could attend camp if they had overweight/obesity, were lonely, unhappy, or had social or family-related problems. In this study only children with overweight and obesity were included (n:185). OE, BE, and QoL were measured using self-reported questionnaires. In total, 38 % of the children reported regular BE at baseline. Regular OE, occasional BE, and occasional OE was reported by 14 %, 13 %, and 11 %, respectively, while 24 % reported no eating-related problems. The relative risk of experiencing eating-related problems decreased at 10-weeks compared to baseline. Additionally, the probability of regular OE (RR 0.12 (95 % CI 0.04;0.38) (X
2 = 8.44, p = 0.004)) and regular BE (RR 0.01 (95 % CI 0.00;0.11) (X2 = 9.91, p = 0.002)) remained lower at 52-weeks relative to baseline. All QoL dimensions improved after camp, and the presence of self-reported OE and regular BE at baseline was significantly associated with lower QoL at baseline, 10 and 52-weeks. Children self-reporting OE and BE may be a particular vulnerable group that needs more support from camp staff and healthcare professionals to improve QoL. clinicaltrials.gov with ID: NCT04522921 [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
34. Specificity of Early Childhood Hyperphagia Profiles in Neurogenetic Conditions.
- Author
-
Andrews, Sara M., Panjwani, Anita A., Potter, Sarah Nelson, Hamrick, Lisa R., Wheeler, Anne C., and Kelleher, Bridgette L.
- Subjects
HYPERPHAGIA ,PRADER-Willi syndrome ,WILLIAMS syndrome ,ANGELMAN syndrome ,EXTERNALIZING behavior - Abstract
Hyperphagia is highly penetrant in Prader-Willi syndrome (PWS) and has increasingly been reported in other neurogenetic conditions (NGC). The Hyperphagia Questionnaire (HQ) was completed by caregivers of 4–8-year-olds with PWS (n = 17), Angelman syndrome (AS; n = 22), Williams syndrome (WS; n = 25), or low-risk controls (LRC; n = 35). All NGC groups were significantly elevated in HQ Total and Behavior scores compared to LRC. Only AS and WS were significantly elevated in the Drive domain, and only PWS in the Severity domain. After controlling for externalizing behavior, HQ Total scores were higher for PWS relative to other groups. Hyperphagic symptoms may not differentiate PWS from other NGCs in early childhood. However, hyperphagic phenotypes may be most severe in PWS. Further investigation of these profiles may inform etiology and syndrome-specific treatments. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
35. Behavioral changes in patients with Prader-Willi syndrome receiving diazoxide choline extended-release tablets compared to the PATH for PWS natural history study.
- Author
-
Strong, Theresa V., Miller, Jennifer L., McCandless, Shawn E., Gevers, Evelien, Yanovski, Jack A., Matesevac, Lisa, Bohonowych, Jessica, Ballal, Shaila, Yen, Kristen, Hirano, Patricia, Cowen, Neil M., and Bhatnagar, Anish
- Subjects
PRADER-Willi syndrome ,NATURAL history ,CHOLINE ,HYPERPHAGIA ,MISSING data (Statistics) - Abstract
Background: Prader-Willi syndrome (PWS) is a rare neurobehavioral-metabolic disease caused by the lack of paternally expressed genes in the chromosome 15q11-q13 region, characterized by hypotonia, neurocognitive problems, behavioral difficulties, endocrinopathies, and hyperphagia resulting in severe obesity if energy intake is not controlled. Diazoxide choline extended-release (DCCR) tablets have previously been evaluated for their effects on hyperphagia and other behavioral complications of people with PWS in a Phase 3 placebo-controlled study of participants with PWS, age 4 and older with hyperphagia (C601) and in an open label extension study, C602. Methods: To better understand the longer-term impact of DCCR, a cohort from PATH for PWS, a natural history study that enrolled participants with PWS age 5 and older, who met the C601 age, weight and baseline hyperphagia inclusion criteria and had 2 hyperphagia assessments ≥ 6 months apart, were compared to the C601/C602 cohort. Hyperphagia was measured using the Hyperphagia Questionnaire for Clinical Trials (HQ-CT, range 0–36). The primary analysis used observed values with no explicit imputation of missing data. A sensitivity analysis was conducted in which all missing HQ-CT assessments in the C601/C602 cohort were assigned the highest possible value (36), representing the worst-case scenario. Other behavioral changes were assessed using the Prader-Willi Syndrome Profile questionnaire (PWSP). Results: Relative to the PATH for PWS natural history study cohort, the DCCR-treated C601/C602 cohort showed significant improvements in HQ-CT score at 26 weeks (LSmean [SE] -8.3 [0.75] vs. -2.5 [0.43], p < 0.001) and 52 weeks (LSmean [SE] -9.2 [0.77] vs. -3.4 [0.47], p < 0.001). The comparison between the cohorts remained significant in the worst-case imputation sensitivity analysis. There were also significant improvements in all domains of the PWSP at 26 weeks (all p < 0.001) and 52 weeks (all p ≤ 0.003) for C601/C602 participants compared to the PATH for PWS participants. Conclusion: Long-term administration of DCCR to people with PWS resulted in changes in hyperphagia and other behavioral complications of PWS that are distinct from the natural history of the syndrome as exemplified by the cohort from PATH for PWS. The combined effects of administration of DCCR should reduce the burden of the syndrome on the patient, caregivers and their families, and thereby may benefit people with PWS and their families. Trial Registration: Clinical study C601 was originally registered on ClinicalTrials.gov on February 22, 2018 (NCT03440814). Clinical study C602 was originally registered on ClinicalTrials.gov on October 22, 2018 (NCT03714373). PATH for PWS was originally registered on ClinicalTrials.gov on October 24, 2018 (NCT03718416). [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
36. Emerging Insights into the Role of BDNF on Health and Disease in Periphery.
- Author
-
Ichimura-Shimizu, Mayuko, Kurrey, Khuleshwari, Miyata, Misaki, Dezawa, Takuya, Tsuneyama, Koichi, and Kojima, Masami
- Subjects
- *
BRAIN-derived neurotrophic factor , *SINGLE nucleotide polymorphisms , *NEURAL transmission , *KNOCKOUT mice , *NEURAL development , *ENERGY metabolism - Abstract
Brain-derived neurotrophic factor (BDNF) is a growth factor that promotes the survival and growth of developing neurons. It also enhances circuit formation to synaptic transmission for mature neurons in the brain. However, reduced BDNF expression and single nucleotide polymorphisms (SNP) are reported to be associated with functional deficit and disease development in the brain, suggesting that BDNF is a crucial molecule for brain health. Interestingly, BDNF is also expressed in the hypothalamus in appetite and energy metabolism. Previous reports demonstrated that BDNF knockout mice exhibited overeating and obesity phenotypes remarkably. Therefore, we could raise a hypothesis that the loss of function of BDNF may be associated with metabolic syndrome and peripheral diseases. In this review, we describe our recent finding that BDNF knockout mice develop metabolic dysfunction-associated steatohepatitis and recent reports demonstrating the role of one of the BDNF receptors, TrkB-T1, in some peripheral organ functions and diseases, and would provide an insight into the role of BDNF beyond the brain. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
37. Emotion‐Driven Eating and Overeating Among Fourth Graders: The Roles of Body Image, Academic Achievement, and Peer and School Factors.
- Author
-
Somers, Cheryl, Kevern, Carla, Moore, E. Whitney G., Centeio, Erin E., Kulik, Noel, Piotter, Bridget, Garn, Alex, and McCaughtry, Nate
- Subjects
- *
READING , *ELEMENTARY schools , *MATHEMATICS , *RESEARCH funding , *PSYCHOLOGY of school children , *AFFINITY groups , *SEX distribution , *EMOTIONS , *BODY image , *PATH analysis (Statistics) , *DESCRIPTIVE statistics , *HYPERPHAGIA , *EATING disorders , *MOTIVATION (Psychology) , *FOOD habits , *ACADEMIC achievement , *METROPOLITAN areas , *COMPULSIVE eating , *SOCIAL support , *INTERPERSONAL relations , *STUDENT attitudes , *CONFIDENCE intervals , *DATA analysis software - Abstract
BACKGROUND: Eating patterns such as breakfast consumption and fruit and vegetable intake have been associated with academic achievement and cognitive function. METHOD: The purpose of this study was to learn more about psychological (emotion‐driven eating) and behavioral (over‐eating) eating patterns and motives, and the roles of body image, academic achievement (reading and math), and social supports (peer acceptance and school attachment), among 378 fourth‐grade students (55% boys) from 14 classrooms across 6 schools within a large Midwestern urban area. RESULTS: Results were analyzed through a 2‐group (male and female) path analysis. Boys' overeating (R2 = 9%) was not significantly predicted. Their emotional eating (R2 = 22.2%) was negatively, significantly predicted by peer acceptance and interaction of peer acceptance and school attachment. Girls' overeating (R2 = 13.6%) was negatively, significantly predicted by positive body image. Girls' emotional eating (R2 = 24.1%) was negatively significantly predicted by positive body image, math scores, and peer acceptance. CONCLUSIONS: Boys' and girls' eating patterns are differentially affected by their school experiences. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
38. Using camera traps to assess body condition of brown bears in Hokkaido.
- Author
-
Kanazawa, Shuhei, Nomura, Kento, Tani, Koya, Ishibashi, Yuki, Tsukano, Moemi, Kawamura, Kurumi, Toyoshima, Hisaaki, and Sato, Yoshikazu
- Subjects
- *
BROWN bear , *SPRING , *AUTUMN , *CAMCORDERS , *SOCIAL dominance , *HUMAN-animal relationships - Abstract
Assessing the seasonal changes in body condition (BC) of animals is important for understanding their reproduction and survival, as well as human–animal interaction. Visual or photographic assessment of BC has, however, been limited to species in open habitats or to specific times and locations. To noninvasively assess the seasonal changes in the entire local population of brown bears (Ursus arctos) inhabiting the forest habitat in eastern Hokkaido, Japan, we evaluated their BC using camera-trapping during 2015–2017. We assigned a 5-point BC score (BCS) for each individual based on the images, and examined seasonal changes in BCS by sex–age classes. Out of the 1,714 events in which brown bears were recorded, sex–age classes including adult males, subadults, females with offspring, and solitary adult females, could be determined in 887 events. Overall, BCS tended to decrease from spring to summer, with the lowest value in July, and tended to increase toward autumn, with the highest value in November. The BCS of adult male bears showed the highest seasonal variation, whereas that of subadults showed the least variation. Adult females, both solitary and those with offspring, showed intermediate seasonal variation in BCS compared with adult males and subadults. These seasonal changes were considered to be a general pattern and point to the amount of accumulated body fat. Adult males have a larger home range and, because of their social dominance, can exploit higher quality resources than can be exploited by other sex–age classes, which results in them being able to accumulate relatively more fat during hyperphagia. Females with offspring tended to have a lesser increase in BCS after August and lower BCS in autumn than did solitary adults. We were able to demonstrate the possibility of evaluating the BC of individuals and their seasonal changes by examining BCS based on the videos taken by camera traps. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
39. Nuclear receptor 5A2 regulation of Agrp underlies olanzapine-induced hyperphagia
- Author
-
Zapata, Rizaldy C, Zhang, Dinghong, Libster, Avraham, Porcu, Alessandra, Montilla-Perez, Patricia, Nur, Aisha, Xu, Baijie, Zhang, Zhi, Correa, Stephanie M, Liu, Chen, Telese, Francesca, and Osborn, Olivia
- Subjects
Biological Psychology ,Pharmacology and Pharmaceutical Sciences ,Biomedical and Clinical Sciences ,Psychology ,Neurosciences ,Genetics ,Nutrition ,Behavioral and Social Science ,Obesity ,Aetiology ,2.1 Biological and endogenous factors ,Cancer ,Cardiovascular ,Metabolic and endocrine ,Stroke ,Animals ,Humans ,Mice ,Agouti-Related Protein ,Antipsychotic Agents ,Eating ,Hyperphagia ,Hypothalamus ,Olanzapine ,Receptors ,Cytoplasmic and Nuclear ,Weight Gain ,Biological Sciences ,Medical and Health Sciences ,Psychology and Cognitive Sciences ,Psychiatry ,Clinical sciences ,Biological psychology ,Clinical and health psychology - Abstract
Antipsychotic (AP) drugs are efficacious treatments for various psychiatric disorders, but excessive weight gain and subsequent development of metabolic disease remain serious side effects of their use. Increased food intake leads to AP-induced weight gain, but the underlying molecular mechanisms remain unknown. In previous studies, we identified the neuropeptide Agrp and the transcription factor nuclear receptor subfamily 5 group A member 2 (Nr5a2) as significantly upregulated genes in the hypothalamus following AP-induced hyperphagia. While Agrp is expressed specifically in the arcuate nucleus of the hypothalamus and plays a critical role in appetite stimulation, Nr5a2 is expressed in both the CNS and periphery, but its role in food intake behaviors remains unknown. In this study, we investigated the role of hypothalamic Nr5a2 in AP-induced hyperphagia and weight gain. In hypothalamic cell lines, olanzapine treatment resulted in a dose-dependent increase in gene expression of Nr5a2 and Agrp. In mice, the pharmacological inhibition of NR5A2 decreased olanzapine-induced hyperphagia and weight gain, while the knockdown of Nr5a2 in the arcuate nucleus partially reversed olanzapine-induced hyperphagia. Chromatin-immunoprecipitation studies showed for the first time that NR5A2 directly binds to the Agrp promoter region. Lastly, the analysis of single-cell RNA seq data confirms that Nr5a2 and Agrp are co-expressed in a subset of neurons in the arcuate nucleus. In summary, we identify Nr5a2 as a key mechanistic driver of AP-induced food intake. These findings can inform future clinical development of APs that do not activate hyperphagia and weight gain.
- Published
- 2023
40. Differentiating monogenic and syndromic obesities from polygenic obesity: Assessment, diagnosis, and management
- Author
-
Angela K. Fitch, Sonali Malhotra, and Rushika Conroy
- Subjects
Hyperphagia ,Melanocortin-4 receptor pathway ,Monogenic obesity ,Polygenic obesity ,Syndromic obesity ,Targeted pharmacotherapy ,Nutrition. Foods and food supply ,TX341-641 ,Medicine - Abstract
Background: Obesity is a multifactorial neurohormonal disease that results from dysfunction within energy regulation pathways and is associated with increased morbidity, mortality, and reduced quality of life. The most common form is polygenic obesity, which results from interactions between multiple gene variants and environmental factors. Highly penetrant monogenic and syndromic obesities result from rare genetic variants with minimal environmental influence and can be differentiated from polygenic obesity depending on key symptoms, including hyperphagia; early-onset, severe obesity; and suboptimal responses to nontargeted therapies. Timely diagnosis of monogenic or syndromic obesity is critical to inform management strategies and reduce disease burden. We outline the physiology of weight regulation, role of genetics in obesity, and differentiating characteristics between polygenic and rare genetic obesity to facilitate diagnosis and transition toward targeted therapies. Methods: In this narrative review, we focused on case reports, case studies, and natural history studies of patients with monogenic and syndromic obesities and clinical trials examining the efficacy, safety, and quality of life impact of nontargeted and targeted therapies in these populations. We also provide comprehensive algorithms for diagnosis of patients with suspected rare genetic causes of obesity. Results: Patients with monogenic and syndromic obesities commonly present with hyperphagia (ie, pathologic, insatiable hunger) and early-onset, severe obesity, and the presence of hallmark characteristics can inform genetic testing and diagnostic approach. Following diagnosis, specialized care teams can address complex symptoms, and hyperphagia is managed behaviorally. Various pharmacotherapies show promise in these patient populations, including setmelanotide and glucagon-like peptide-1 receptor agonists. Conclusion: Understanding the pathophysiology and differentiating characteristics of monogenic and syndromic obesities can facilitate diagnosis and management and has led to development of targeted pharmacotherapies with demonstrated efficacy for reducing body weight and hunger in the affected populations.
- Published
- 2024
- Full Text
- View/download PDF
41. Computerized Response Training Obesity Treatment (CC)
- Author
-
Flinders University, University of Exeter, Radboud University Medical Center, and University of Oregon
- Published
- 2023
42. Ghrelin in Patients With a Rare Disease Associated With Intellectual Disability, and Hyperphagia, and/or Overweight, and/or Obesity (HOGRID)
- Published
- 2023
43. Prader-Willi and Angelman Syndromes: Mechanisms and Management
- Author
-
Ma, Van K, Mao, Rong, Toth, Jessica N, Fulmer, Makenzie L, Egense, Alena S, and Shankar, Suma P
- Subjects
Biological Sciences ,Biomedical and Clinical Sciences ,Genetics ,Clinical Research ,Brain Disorders ,Rare Diseases ,Congenital Structural Anomalies ,Intellectual and Developmental Disabilities (IDD) ,Pediatric ,Congenital ,Quality Education ,chromosome 15 ,developmental delay ,hyperphagia ,imprinting disorders ,obesity ,uniparental disomy ,Clinical Sciences ,Oncology and Carcinogenesis ,Clinical sciences ,Oncology and carcinogenesis - Abstract
Prader-Willi syndrome (PWS) and Angelman syndrome (AS) are genetic imprinting disorders resulting from absent or reduced expression of paternal or maternal genes in chromosome 15q11q13 region, respectively. The most common etiology is deletion of the maternal or paternal 15q11q13 region. Methylation is the first line for molecular diagnostic testing; MS-MLPA is the most sensitive test. The molecular subtype of PWS/AS provides more accurate recurrence risk information for parents and for the individual affected with the condition. Management should include a multidisciplinary team by various medical subspecialists and therapists. Developmental and behavioral management of PWS and AS in infancy and early childhood includes early intervention services and individualized education programs for school-aged children. Here, we compare and discuss the mechanisms, pathophysiology, clinical features, and management of the two imprinting disorders, PWS and AS.
- Published
- 2023
44. Association between maternal eating and young child feeding in a community sample
- Author
-
Singh, Simar, Cordeiro, Alana, Epel, Elissa, Coccia, Michael, Laraia, Barbara, Adler, Nancy, and Bush, Nicole R
- Subjects
Public Health ,Biomedical and Clinical Sciences ,Nutrition and Dietetics ,Health Sciences ,Eating Disorders ,Pediatric ,Nutrition ,Clinical Research ,Behavioral and Social Science ,Basic Behavioral and Social Science ,Mental Health ,Obesity ,Good Health and Well Being ,Female ,Infant ,Humans ,Child ,Preschool ,Child ,Overweight ,Thinness ,Mother-Child Relations ,Feeding Behavior ,Mothers ,Hyperphagia ,Surveys and Questionnaires ,Child Behavior ,Body Mass Index ,Eating ,Maternal nutrition ,Public health ,Postpartum ,Child weight ,Child feeding ,Nursing ,Paediatrics and Reproductive Medicine ,Public Health and Health Services ,Obstetrics & Reproductive Medicine ,Reproductive medicine ,Midwifery - Abstract
BackgroundEarly childhood is a pivotal period for the development of healthy eating practices. One way to promote child health is to identify early modifiable factors that affect child eating and weight. Given the intergenerational transmission of eating behaviors, this study examined how mothers' eating behaviors were associated with child feeding practices, and whether child weight-for-length (z-WFL) moderated this relation, in a community sample.MethodsParticipants were 72 mother-child dyads. Maternal eating behaviors-emotional, external and restrained-were assessed 9-months postpartum, using the Dutch Eating Behavior Questionnaire. Child feeding-restrictive, pressure, and concern about overeating/overweight or undereating/underweight-was measured using the Infant Feeding Questionnaire, and child z-WFL were assessed 18-months postpartum. Linear regressions were used to test the main effect of maternal eating and the interaction effect of maternal eating and child z-WFL, on child feeding practices.ResultsMaternal restrained eating was associated with child pressure feeding, and contrarily with concerns about overeating/overweight. However, a significant interaction between child z-WFL and both maternal emotional and external eating were found with regard to concern about child undereating/underweight. Paradoxically, among children who weighed more, greater maternal emotional and greater external eating were associated with greater concern about child undereating/underweight.ConclusionsIn this community sample, mothers were more likely to report contradictory feeding practices and concerns, suggesting complicated relations among a mother's own eating behavior, her child's weight, and her perceptions of child eating and weight. This may indicate a need for better communication and support of infant feeding practices.Trial registrationData was collected as part of two grants (MAMAS Grant ID: HL097973-01; SEED Grant ID: HL116511-02) conducted at the University of California, San Francisco (UCSF). All subjects gave their informed consent for inclusion before they participated in the study. The study was conducted in accordance with the Declaration of Helsinki, and the protocol was approved by institutional review board at UCSF.
- Published
- 2023
45. Clinical Trials in Prader–Willi Syndrome: A Review
- Author
-
Mahmoud, Ranim, Kimonis, Virginia, and Butler, Merlin G
- Subjects
Biological Sciences ,Genetics ,Brain Disorders ,Congenital Structural Anomalies ,Clinical Research ,Pediatric ,Behavioral and Social Science ,Nutrition ,Intellectual and Developmental Disabilities (IDD) ,Rare Diseases ,Obesity ,Metabolic and endocrine ,Mental health ,Female ,Humans ,Prader-Willi Syndrome ,Transcranial Direct Current Stimulation ,Hyperphagia ,Anxiety ,Mothers ,Prader-Willi syndrome ,obesity ,hyperphagia ,clinical trials ,genetics ,Prader–Willi syndrome ,Other Chemical Sciences ,Other Biological Sciences ,Chemical Physics ,Biochemistry and cell biology ,Microbiology ,Medicinal and biomolecular chemistry - Abstract
Prader-Willi syndrome (PWS) is a complex, genetic, neurodevelopmental disorder. PWS has three molecular genetic classes. The most common defect is due to a paternal 15q11-q13 deletion observed in about 60% of individuals. This is followed by maternal disomy 15 (both 15 s from the mother), found in approximately 35% of cases. the remaining individuals have a defect of the imprinting center that controls the activity of imprinted genes on chromosome 15. Mild cognitive impairment and behavior problems in PWS include self-injury, anxiety, compulsions, and outbursts in childhood, impacted by genetic subtypes. Food seeking and hyperphagia can lead to morbid obesity and contribute to diabetes and cardiovascular or orthopedic problems. The control of hyperphagia and improving food-related behaviors are the most important unmet needs in PWS and could be addressed with the development of a new therapeutic agent, as currently no approved therapeutics exist for PWS treatment. The status of clinical trials with existing results for the management of obesity and hyperphagia in PWS will be discussed in this review, including treatments such as beloranib, setmelanotide, a diazoxide choline controlled-release tablet (DCCR), an unacylated ghrelin analogue, oxytocin and related compounds, glucagon-like peptide 1 receptor agonists, surgical intervention, and transcranial direct-current stimulation.
- Published
- 2023
46. Skin picking: the overlooked cutaneous manifestation of Prader-Willi syndrome
- Author
-
Patrocinio, Joao, Frade, Joana, Sousa, Diogo, Correia, Catarina, and Filipe, Paulo
- Subjects
dermatillomania ,hyperphagia ,N-acetylcysteine ,obesity ,picking ,Prader-Willi ,skin - Published
- 2023
47. Psychometric properties of the Eating in the Absence of Hunger Questionnaire in treatment-seeking adults with overweight and obesity
- Author
-
Pasquale, Ellen K, Manzano, Michael A, Strong, David R, Eichen, Dawn M, Tanofsky-Kraff, Marian, and Boutelle, Kerri N
- Subjects
Biomedical and Clinical Sciences ,Nutrition and Dietetics ,Psychology ,Behavioral and Social Science ,Clinical Research ,Obesity ,Brain Disorders ,Mental Health ,Eating Disorders ,Nutrition ,Mental Illness ,Female ,Humans ,Male ,Middle Aged ,Adult ,Surveys and Questionnaires ,Psychometrics ,Overweight ,Hyperphagia ,Hunger ,Adults ,Eating in the Absence of Hunger Questionnaire ,Overeating ,Psychometric properties ,Nutrition & Dietetics - Abstract
Understanding eating behaviors that contribute to overweight and obesity (OW/OB) is an important public health objective. One eating behavior known to contribute to overeating is eating in the absence of hunger (EAH). The Eating in the Absence of Hunger Questionnaire for Children was developed to assess external events and internal experiences that lead children to overeat. Despite the measure's adaptation for use with adults (i.e., EAH-A), its psychometric properties within this population have not been explored. This study assessed the psychometric properties of the EAH-A in sample of 311 treatment-seeking adults with OW/OB (mean BMI = 34.5 [5.1]; mean age = 46.3 [12.1]; 81.7% female; 20.6% Latinx, 59.2% white). The EAH-A contains 14 items and assesses three domains: negative affect eating (EAH-NAE), external eating, and fatigue/boredom eating, through two parallel sets of items assessing initiating EAH and continuing EAH. Exploratory Factor Analysis was performed with promax rotation and maximum likelihood factor extraction. Results supported a unitary factor of EAH, with scale responses driven by EAH-NAE items. Results may be explained in part by scale structure and domain imbalance favoring EAH-NAE items, or the true internal structure of EAH may consist of a singular latent construct. Follow-up analyses indicated redundancy of the scale's parallel sections. If researchers are primarily interested in EAH-NAE, only the three "start eating" or "keep eating" items may be needed. This study highlights the importance of validating the psychometric properties of a measure within intended populations to ensure interpretations are valid.
- Published
- 2023
48. Das Bardet-Biedl-Syndrom
- Author
-
Pape, L., Cetiner, M., König, J., Oh, J., v. Schnurbein, J., Wiegand, S., Grüters, A., and Kühnen, P.
- Published
- 2024
- Full Text
- View/download PDF
49. Adipositas beim Prader-Willi-Syndrom (PWS): Aktuelle Therapieansätze aus ernährungswissenschaftlicher und endokrinologisch-diabetologischer Sicht
- Author
-
Schweiger, Barbara, Mühleder, Johannes, and Laimer, Sandra
- Published
- 2024
- Full Text
- View/download PDF
50. Hyperphagia and impulsivity: use of self-administered Dykens’ and in-house impulsivity questionnaires to characterize eating behaviors in children with severe and early-onset obesity
- Author
-
Lara Arnouk, Hélène Chantereau, Sophie Courbage, Patrick Tounian, Karine Clément, Christine Poitou, and Béatrice Dubern
- Subjects
Childhood obesity ,Eating behaviors ,Hyperphagia ,Hypothalamus ,Genetics ,Dykens’ questionnaire ,Medicine - Abstract
Abstract Background The determinants of early-onset obesity ( International Obesity Task Force [IOTF] 30) of different etiologies (hypothalamic obesity [HO], intellectual disability with obesity [IDO], common polygenic obesity [CO]) were prospectively included. BMI history and responses from the Dykens’ Hyperphagia Questionnaire and an in-house Impulsivity Questionnaire at first visit were compared between groups. Results This cohort of 75 children (39 girls; mean age ± standard deviation [SD] 10.8 ± 4.4 years) had severe, early-onset obesity at an age of 3.8 ± 2.7 years, with a BMI Z-score of 4.9 ± 1.5. BMI history varied between the 3 groups, with earlier severe obesity in the HO group versus 2 other groups (BMI > IOTF40 at 3.4 ± 1.6 vs. 4.6 ± 1.6 and 8.4 ± 4.1 years for the IDO and CO groups, respectively [P 19) and impulsivity (score > 7) were found in 50 (67%) and 11 children (15%), respectively, with no difference between the HO, IDO and CO groups regarding the number of patients with hyperphagia (10 [67%], 14 [74%], and 26 [63%] children, respectively) or impulsivity (2 [13%], 1 [7%], and 8 [19%] children, respectively). Children with food impulsivity had significantly higher total and severity scores on the Dykens’ Questionnaire versus those without impulsivity. Conclusion The Dykens’ and Impulsivity questionnaires can help diagnose severe hyperphagia with/without food impulsivity in children with early-onset obesity, regardless of disease origin. Their systematic use can allow more targeted management of food access control in clinical practice and monitor the evolution of eating behavior in the case of innovative therapeutic targeting hyperphagia.
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.